Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 26 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | C03XA01 | - | - | - | - | 2件: 67 67, 72 💬
| ||||||||||||||
2 | Desmopressin | 1件: Desmopressin Desmopressin | 1件: Desmopressin
Desmopressin
💬2. Desmopressin
| 2件: AVPR2 AVPR2,F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D si ... | 5件: 6 6, 64, 72, 225, 288 💬
| ||||||||||||||
3 | Desmopressin intranasal | 1件: Desmopressin Desmopressin | 1件: Desmopressin
Desmopressin
💬3. Desmopressin intranasal
| 2件: AVPR2 AVPR2,F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D si ... | 1件: 72 72 💬3. Desmopressin intranasal
| ||||||||||||||
4 | Desmopressin Oral Melt | 1件: Desmopressin Desmopressin | 1件: Desmopressin
Desmopressin
💬4. Desmopressin Oral Melt
| 2件: AVPR2 AVPR2,F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D si ... | 1件: 72 72 💬4. Desmopressin Oral Melt
| ||||||||||||||
5 | Empagliflozin | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬5. Empagliflozin
| 1件: SLC5A2 SLC5A2 💬5. Empagliflozin
| - | 6件: 58 58, 65, 67, 72, 97, 257 💬
| ||||||||||||||
6 | Empagliflozin 25 MG | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬6. Empagliflozin 25 MG
| 1件: SLC5A2 SLC5A2 💬6. Empagliflozin 25 MG
| - | 1件: 72 72 💬6. Empagliflozin 25 MG
| ||||||||||||||
7 | Empagliflozin 25mg | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬7. Empagliflozin 25mg
| 1件: SLC5A2 SLC5A2 💬7. Empagliflozin 25mg
| - | 1件: 72 72 💬7. Empagliflozin 25mg
| ||||||||||||||
8 | Empagliflozin 25mg Tbl | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬8. Empagliflozin 25mg Tbl
| 1件: SLC5A2 SLC5A2 💬8. Empagliflozin 25mg Tbl
| - | 1件: 72 72 💬8. Empagliflozin 25mg Tbl
| ||||||||||||||
9 | EXENATIDE | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬9. EXENATIDE
| 1件: GLP1R GLP1R 💬9. EXENATIDE
| 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 6 6, 17, 72, 78, 193, 233 💬
| ||||||||||||||
10 | Experimental: CRH administration | - | - | - | - | 2件: 72 72, 78 💬
|